Dr. Bally is the Head of Advanced Therapeutics at the BC Cancer Agency and a Professor within the Department of Pathology and Laboratory Medicine at UBC. Dr. Bally is an authority in liposomal drug delivery and his work has led to one approved product and another in late stage clinical trials. Dr Bally was a co-founder of three Vancouver-based companies and has authored over 135 scientific articles and been an inventor on over 30 patents.